Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio
Authors
Keywords
Biomarkers, Neutrophils, Inflammation, Lymphocytes, Blood counts, Blood, Pneumonia, White blood cells
Journal
PLoS One
Volume 12, Issue 3, Pages e0173947
Publisher
Public Library of Science (PLoS)
Online
2017-03-17
DOI
10.1371/journal.pone.0173947
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis
- (2016) Diego Viasus et al. JOURNAL OF INFECTION
- Neutrophiltolymphocyte ratio: A novel and simple prognostic marker for infective endocarditis
- (2015) Mehmet Bozbay et al. JOURNAL OF CRITICAL CARE
- Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia
- (2015) Pedro P. España et al. JOURNAL OF INFECTION
- Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin
- (2015) S. Bello et al. RESPIRATORY MEDICINE
- Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia
- (2014) Jordi Adamuz et al. JOURNAL OF INFECTION
- Community-Acquired Pneumonia
- (2014) Richard G. Wunderink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Midregional proadrenomedullin for prognosis in community-acquired pneumonia: A systematic review
- (2014) Rodrigo Cavallazzi et al. RESPIRATORY MEDICINE
- The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers
- (2014) Olga Rajas et al. BMC Pulmonary Medicine
- Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia
- (2012) Caroline Courtais et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia
- (2012) Cornelis P. C. de Jager et al. PLoS One
- Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia
- (2012) M. Kolditz et al. RESPIRATORY MEDICINE
- Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm
- (2011) Werner C Albrich et al. BMC INFECTIOUS DISEASES
- Cardiovascular and Inflammatory Biomarkers to Predict Short- and Long-Term Survival in Community-acquired Pneumonia
- (2010) Stefan Krüger et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prognostic value of procalcitonin in community-acquired pneumonia
- (2010) P. Schuetz et al. EUROPEAN RESPIRATORY JOURNAL
- Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
- (2010) J. D. Chalmers et al. THORAX
- Midregional Proadrenomedullin as a Prognostic Tool in Community-Acquired Pneumonia
- (2009) David T. Huang et al. CHEST
- Prospective Comparison of Severity Scores for Predicting Clinically Relevant Outcomes for Patients Hospitalized With Community-Acquired Pneumonia
- (2009) Pedro Pablo España Yandiola et al. CHEST
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
- (2008) Khaled M. Sarraf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started